| Literature DB >> 35893194 |
Hoyoung Wang1, Hoonsub So2, Sung Woo Ko3, Seok Won Jung2, Sung-Jo Bang2, Eun Ji Park4.
Abstract
Gallstone is a common health problem. Cholesterol stone accounts for 90% of stones in the United States and Europe, but East Asia has a high proportion of pigment stone. The aim of this study was to determine the relationship between modifiable metabolic factors and gallstone in a region with a high prevalence of pigment stone. Among 3159 participants who underwent health screening at Ulsan University Hospital from March 2014 to June 2019, 178 patients were diagnosed with gallstone using abdominal ultrasonography; 2860 participants were selected as a control group. Demographic and laboratory data, and a medical questionnaire were obtained. Hypertension and diabetes mellitus were more prevalent in the gallstone group. Age, waist circumference, systolic blood pressure (SBP) ≥ 140 mmHg, fasting blood glucose, HbA1c ≥ 6.5%, visceral fat index, normal-attenuated muscle area index, and engaging in vigorous exercise for ≥2 days per week were associated with gallstone by univariate analysis. Through multivariate logistic regression analysis, HbA1c ≥ 6.5% (odds ratio (OR) 1.98, 95% confidence interval (CI) 1.31-2.98), and 2 or more days of vigorous exercise per week (OR 0.66, 95% CI 0.45-0.95) remained significant. The association persisted after adjusted analysis for age and sex. HbA1c ≥ 6.5% were positively associated with the gallstone. Vigorous exercise for at least 2 days weekly may be related to a lower risk of gallstone formation.Entities:
Keywords: blood glucose; blood pressure; exercise; gallstones
Year: 2022 PMID: 35893194 PMCID: PMC9329956 DOI: 10.3390/healthcare10081372
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Segmental abdominal body fat and muscle analysis at the L3 vertebra on abdominopelvic computed tomography. SFA, subcutaneous fat area; VRA, visceral fat area; LAMA, low-attenuated abdominal muscle area; NAMA, normal-attenuated muscle area.
Figure 2Overview of the study population.
Baseline characteristics of study participants.
| No Gallstone | Gallstone | ||
|---|---|---|---|
| Age, mean (SD) | 55.1 (8.3) | 57.4 (8.5) | <0.001 |
| Gender, no (%) | 0.750 | ||
| Female | 1178 (41.2) | 76 (42.7) | |
| Male | 1682 (58.8) | 102 (57.3) | |
| Height, cm, mean (SD) | 165.1 (8.7) | 164.5 (9.3) | 0.338 |
| Weight, kg, mean (SD) | 66.0 (11.8) | 66.6 (11.5) | 0.471 |
| BMI, kg/m2, mean (SD) | 24.1 (3.1) | 24.5 (3.1) | 0.087 |
| Chronic disease, no (%) | |||
| Hypertension | 977 (34.2) | 86 (48.3) | <0.001 |
| Diabetes mellitus | 366 (12.8) | 45 (25.3) | <0.001 |
| Dyslipidemia | 447 (15.6) | 34 (19.1) | 0.260 |
| Smoking, no (%) | 0.581 | ||
| Never smoker | 1487 (52.0) | 93 (52.2) | |
| Ex-smoker | 758 (26.5) | 42 (23.6) | |
| Current smoker | 615 (21.5) | 43 (24.2) | |
| Alcohol consumption, no (%) | 0.960 | ||
| No | 1159 (40.5) | 73 (41.0) | |
| Yes | 1701 (59.5) | 105 (59.0) |
BMI, body mass index.
Univariate analysis of risk factors for gallstone.
| No Gallstone | Gallstone | ||
|---|---|---|---|
| Age, mean (SD) | 55.1 (8.3) | 57.4 (8.5) | <0.001 |
| Gender, no (%) | 0.750 | ||
| Female | 1178 (41.2) | 76 (42.7) | |
| Male | 1682 (58.8) | 102 (57.3) | |
| Waist circumference, cm, mean (SD) | 85.4 (8.1) | 87.1 (8.0) | 0.007 |
| SBP, no (%) | 0.018 | ||
| ≥140 mmHg | 335 (11.7) | 32 (18.0) | |
| <140 mmHg | 2525 (88.3) | 146 (82.0) | |
| Serum indices | |||
| Hb, g/dL, mean (SD) | 14.4 (1.5) | 14.3 (1.6) | 0.347 |
| Total bilirubin, mg/dL, mean (SD) | 0.9 (0.4) | 0.8 (0.3) | 0.107 |
| Direct bilirubin, mg/dL, mean (SD) | 0.3 (0.1) | 0.3 (0.1) | 0.166 |
| AST, IU/L, mean (SD) | 25.8 (13.8) | 26.4 (14.0) | 0.583 |
| ALT, IU/L, mean (SD) | 27.8 (18.2) | 30.4 (32.5) | 0.277 |
| γGTP, IU/L, mean (SD) | 41.3 (52.4) | 43.2 (61.6) | 0.683 |
| ALP, IU/L, mean (SD) | 65.3 (19.6) | 66.8 (18.6) | 0.333 |
| Total cholesterol, mg/dL, mean (SD) | 190.6 (37.8) | 187.8 (41.4) | 0.334 |
| TG, mg/dL, mean (SD) | 112.8 (76.6) | 117.4 (64.3) | 0.357 |
| HDL-C, mg/dL, mean (SD) | 53.7 (15.9) | 51.7 (15.6) | 0.110 |
| LDL-C, mg/dL, mean (SD) | 130.3 (35.0) | 127.6 (38.7) | 0.335 |
| FBG, mg/dL, mean (SD) | 95.4 (22.4) | 100.9 (26.0) | 0.007 |
| HbA1c, no (%) | <0.001 | ||
| ≥6.5 % | 272 (9.5) | 34 (19.1) | |
| <6.5% | 2588 (90.5) | 144 (80.9) | |
| CCTA indices | |||
| Sfat index, cm2/(kg/m2), mean (SD) | 5.9 (2.0) | 6.2 (2.1) | 0.068 |
| Vfat index, cm2/(kg/m2), mean (SD) | 4.5 (2.2) | 4.9 (2.3) | 0.018 |
| LAMA index, cm2/(kg/m2), mean (SD) | 1.2 (3.8) | 1.2 (0.3) | 0.881 |
| NAMA index, cm2/(kg/m2), mean (SD) | 4.5 (4.2) | 4.2 (1.2) | 0.015 |
| Vigorous exercise, no (%) | 0.015 | ||
| Less than 2 days in a week | 1996 (69.8) | 140 (78.7) | |
| 2 or more days in a week | 864 (30.2) | 38 (21.3) | |
|
| |||
|
|
| ||
| Age, mean (SD) | 1.04 (1.02–1.05) | <0.001 | |
| Gender, no (%) | |||
| Female | 1 | ||
| Male | 0.94 (0.69–1.28) | 0.692 | |
| Waist circumference, cm, mean (SD) | 1.02 (1.01–1.04) | 0.007 | |
| SBP, no (%) | |||
| <140 mmHg | 1 | ||
| ≥140 mmHg | 1.65 (1.09–2.43) | 0.014 | |
| Serum indices | |||
| Hb, g/dL, mean (SD) | 0.95 (0.87–1.05) | 0.347 | |
| Total bilirubin, mg/dL, mean (SD) | 0.74 (0.48–1.10) | 0.152 | |
| Direct bilirubin, mg/dL, mean (SD) | 0.40 (0.11–1.37) | 0.162 | |
| AST, IU/L, mean (SD) | 1.00 (0.99–1.01) | 0.583 | |
| ALT, IU/L, mean (SD) | 1.01 (1.00–1.01) | 0.075 | |
| γGTP, IU/L, mean (SD) | 1.00 (1.00–1.00) | 0.638 | |
| ALP, IU/L, mean (SD) | 1.00 (1.00–1.01) | 0.332 | |
| Total cholesterol, mg/dL, mean (SD) | 1.00 (0.99–1.00) | 0.334 | |
| TG, mg/dL, mean (SD) | 1.00 (1.00–1.00) | 0.429 | |
| HDL-C, mg/dL, mean (SD) | 0.99 (0.98–1.00) | 0.110 | |
| LDL-C, mg/dL, mean (SD) | 1.00 (0.99–1.00) | 0.335 | |
| FBG, mg/dL, mean (SD) | 1.01 (1.00–1.01) | 0.002 | |
| HbA1c, no (%) | |||
| <6.5% | 1 | ||
| ≥6.5% | 2.25 (1.49–3.29) | <0.001 | |
| CCTA indices | |||
| Sfat index, cm2/(kg/m2), mean (SD) | 1.07 (0.99–1.15) | 0.068 | |
| Vfat index, cm2/(kg/m2), mean (SD) | 1.08 (1.01–1.15) | 0.018 | |
| LAMA index, cm2/(kg/m2), mean (SD) | 1.00 (1.00–1.02) | 0.968 | |
| NAMA index, cm2/(kg/m2), mean (SD) | 0.86 (0.76–0.98) | 0.021 | |
| Vigorous exercise, no (%) | |||
| Less than 2 days in a week | 1 | ||
| 2 or more days in a week | 0.63 (0.43–0.90) | 0.013 | |
SBP, systolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γGTP, gamma glutamyltransferase; ALP, alkaline phosphatase; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high-density lipoprotein; LDL-C, low-density lipoprotein; CCTA, coronary CT angiography; Sfat, subcutaneous fat; Vfat, visceral fat; LAMA, low-attenuated muscle area; NAMA, normal-attenuated muscle area.
Multivariate analysis of risk factors for gallstone.
| Multivariate Analysis | Multivariate Analysis | |||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Age | 1.03 (1.01–1.05) | 0.002 | ||
| Waist circumference | 1.01 (0.97–1.04) | 0.636 | 1.01 (0.98–1.04) | 0.693 |
| SBP ≥ 140 mmHg | 1.45 (0.96–2.18) | 0.079 | 1.39 (0.92–12.09) | 0.121 |
| Serum indices | ||||
| HbA1c ≥ 6.5% | 1.98 (1.31–2.98) | 00.001 | 1.93 (1.28–2.91) | |
| ALT | 1.00 (1.00–1.01) | 0.396 | 1.00 (1.00–1.01) | 0.299 |
| CCTA indices | ||||
| Sfat index | 1.02 (0.91–1.13) | 0.762 | 1.06 (0.94–1.18) | 0.341 |
| Vfat index | 1.04 (0.94–1.14) | 0.452 | 1.03 (0.93–1.13) | 0.632 |
| NAMA index | 0.89 (0.76–1.04) | 0.127 | 0.99 (0.90–1.10) | 0.920 |
| Vigorous exercise | ||||
| 2 or more days in a week | 0.66 (0.45–0.95) | 0.026 | 0.64 (0.44–0.92) | 0.018 |
SBP, systolic blood pressure; ALT, alanine aminotransferase; Sfat, subcutaneous fat; Vfat, visceral fat; NAMA, normal-attenuated muscle area.